Israel News Beep
  • News Beep
  • Israel
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology
Israel News Beep
Israel News Beep
  • News Beep
  • Israel
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology

Browsing Tag

novartis

19 posts
BBusiness
Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline
Read More

Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline

  • March 21, 2026
Proposed acquisition supports the Novartis oncology strategy in hormone receptor positive, human epidermal growth factor receptor two-negative (HR+/HER2-)…
HHealthcare
Diseases of Aging and Regenerative medicine (DARe) research at Novartis
Read More

Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients

  • February 27, 2026
Facility expected to be operational in 2028 in Dallas-Fort Worth area, expanding largest RLT manufacturing network in USSite…
BBusiness
Diseases of Aging and Regenerative medicine (DARe) research at Novartis
Read More

Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy

  • February 27, 2026
Adds Avidity’s differentiated muscle-directed Antibody Oligonucleotide Conjugates (AOC) platform and three late-stage programs to industry-leading neuromuscular pipelinePotentially unlocks…
HHealthcare
Diseases of Aging and Regenerative medicine (DARe) research at Novartis
Read More

Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients

  • February 25, 2026
Facility expected to be operational in 2028 in Dallas-Fort Worth area, expanding largest RLT manufacturing network in USSite…
BBusiness
Diseases of Aging and Regenerative medicine (DARe) research at Novartis
Read More

Novartis presents Rhapsido® (remibrutinib) data at AAAAI, showing potential beyond chronic spontaneous urticaria (CSU)

  • February 23, 2026
Analyses from REMIX-1 & -2 studies on CSU disease control and early symptom relief will be presented Phase…
MMedication
Diseases of Aging and Regenerative medicine (DARe) research at Novartis
Read More

Novartis remibrutinib first therapy to achieve Phase III primary endpoint in chronic inducible urticaria (CIndU)

  • February 21, 2026
Statistically significant and clinically meaningful results seen in RemIND trial with complete responses achieved in 3 CIndU types1Remibrutinib,…
BBusiness
Victor Bulto and Thierry Diagana named to 2026 TIME100 Health List
Read More

Victor Bulto and Thierry Diagana named to 2026 TIME100 Health List

  • February 11, 2026
TIME has included Victor Bultó, President of Novartis US, and Thierry Diagana, Global Head of Global Health and…
BBusiness
Diseases of Aging and Regenerative medicine (DARe) research at Novartis
Read More

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

  • February 6, 2026
New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing global research sites…
BBusiness
Diseases of Aging and Regenerative medicine (DARe) research at Novartis
Read More

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjögren’s disease

  • January 16, 2026
Designation based on clinical evidence supporting potential of ianalumab in Sjögren’s disease, including phase III trials1Distinction expedites development…
BBusiness
Diseases of Aging and Regenerative medicine (DARe) research at Novartis
Read More

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

  • January 9, 2026
New 35,000-square-foot facility in Winter Park will expand RLT manufacturing footprint to optimize delivery for patients across southeastern…
HHealthcare
Diseases of Aging and Regenerative medicine (DARe) research at Novartis
Read More

Novartis and US government reach agreement on lowering drug prices in the US

  • December 19, 2025
Novartis agrees to take actions aimed at meeting US Administration priorities for drug pricingAdditional Novartis medicines will be…
BBusiness
Diseases of Aging and Regenerative medicine (DARe) research at Novartis
Read More

Novartis opens new radioligand therapy manufacturing facility in California as part of $23B US expansion plan

  • November 10, 2025
Carlsbad location is company’s third US-based radioligand therapy (RLT) manufacturing site New site expands manufacturing footprint to meet…
Israel News Beep
www.newsbeep.com